VASOTEC Safety Questions, VASOTEC Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about VASOTEC. Our extensive database of VASOTEC adverse events and VASOTEC warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about VASOTEC

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet




VASOTEC Safety Reports

Total VASOTEC reports: 57.
VASOTEC FDA safety alerts: No.
Reported deaths: 1    Reported hospitalizations: 21.
Take VASOTEC Side Effects Survey or Share Your VASOTEC Story. VASOTEC Usage.

Pharmacist from UNITED STATES reported VASOTEC problem on Jan 25, 2007. Male patient, weighting 185.0 lb, was diagnosed with hypertension and was treated with VASOTEC. After drug was administered, patient experienced the following problems/side effects: asthenia, fatigue, renal failure acute. VASOTEC dosage: 20MG PO BID. During the same period patient was treated with CARDURA, DILACOR, DYAZIDE. Patient was hospitalized. Patient recovered.

VASOTEC problem was reported by a Pharmacist from UNITED STATES on Jan 25, 2007. Male patient, weighting 230.0 lb, was diagnosed with hypertension and was treated with VASOTEC. After drug was administered, patient experienced the following problems/side effects: lip swelling, swelling face. VASOTEC dosage: unknown. During the same period patient was treated with ATENOLOL, HYDROCHLOROTHIAZIDE, NORVASC. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported VASOTEC problem on Jan 10, 2007. Female patient, 76 years of age, weighting 206.0 lb, was diagnosed with hypertension and was treated with VASOTEC. After drug was administered, patient experienced the following problems/side effects: bundle branch block, cervicobrachial syndrome, cough, myocardial infarction, myocardial ischaemia. VASOTEC dosage: 5 MG BID PO. During the same period patient was treated with PLAVIX, LIPITOR, ZETIA, COREG, CLARITIN, PERCOCET, ASPIRIN, NIASPAN. Patient recovered.

VASOTEC problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 25, 2007. Female patient, weighting 195.0 lb, was diagnosed with hypertension and was treated with VASOTEC. After drug was administered, patient experienced the following problems/side effects: asthenia, blood pressure increased, chest discomfort, chest pain, cough, dizziness, dysgeusia, dyspnoea. VASOTEC dosage: 2.5 MG Q DAY PO. During the same period patient was treated with VYTORIN, PAXIL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported VASOTEC problem on Feb 07, 2007. Male patient, 58 years of age, weighting 180.0 lb, was diagnosed with schizophrenia and was treated with VASOTEC. After drug was administered, patient experienced the following problems/side effects: abscess, bloody discharge, diabetes mellitus non-insulin-dependent, weight decreased, weight increased. VASOTEC dosage: 5 MG, UNK. During the same period patient was treated with ZESTRIL, ZYPREXA. Patient recovered.

VASOTEC problem was reported by a Physician from UNITED STATES on Jan 26, 2007. Female patient, weighting 200.0 lb, was diagnosed with hypertension and was treated with VASOTEC. After drug was administered, patient experienced the following problems/side effects: acute myocardial infarction, cervicobrachial syndrome, cough, myocardial ischaemia, nasopharyngitis, no therapeutic response. VASOTEC dosage: 5 MG BID PO. During the same period patient was treated with PLAVIX, LIPITOR, ZETIA, COREG, CLARITIN, PERCOCET, ASPIRIN, NIASPAN. Patient recovered.

Health Professional from UNITED STATES reported VASOTEC problem on Feb 02, 2007. Female patient, 44 years of age, was diagnosed with hypertension and was treated with VASOTEC. After drug was administered, patient experienced the following problems/side effects: amnesia, cough, depression, dizziness, feeling abnormal, flushing, hypotension, libido increased, mental disorder. VASOTEC dosage: 10 MG QD PO. During the same period patient was treated with PROCARDIA. Patient recovered.

VASOTEC problem was reported by a Physician from UNITED STATES on Nov 14, 2006. Female patient was treated with VASOTEC. After drug was administered, patient experienced the following problems/side effects: angioedema. VASOTEC dosage: unknown. During the same period patient was treated with ROFECOXIB. Patient recovered.

Consumer or non-health professional from UNITED STATES reported VASOTEC problem on Jan 13, 2006. Female patient, 58 years of age, weighting 250.0 lb, was treated with VASOTEC. After drug was administered, patient experienced the following problems/side effects: renal failure. VASOTEC dosage: unknown. During the same period patient was treated with MONOPRIL, NARCOTICS. Patient recovered.

VASOTEC problem was reported by a Pharmacist from JAPAN on Mar 13, 2007. Male patient, 74 years of age, was treated with VASOTEC. After drug was administered, patient experienced the following problems/side effects: cardiac failure, dyspnoea, overdose. VASOTEC dosage: unknown. During the same period patient was treated with WARFARIN POTASSIUM, WARFARIN POTASSIUM, DIGOXIN, MEVALOTIN, PLETAL. Patient was hospitalized. Patient recovered.

Physician from GERMANY reported VASOTEC problem on June 19, 2006. Female patient, 40 years of age, weighting 154.3 lb, was diagnosed with hypertension and was treated with VASOTEC. After drug was administered, patient experienced the following problems/side effects: angioedema. VASOTEC dosage: unknown. During the same period patient was treated with BISOPROLOL. Patient was hospitalized. Patient recovered.

VASOTEC problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2007. Female patient, 47 years of age, weighting 238.0 lb, was diagnosed with hypertension and was treated with VASOTEC. After drug was administered, patient experienced the following problems/side effects: blood pressure fluctuation, condition aggravated, hypertension, trigger finger. VASOTEC dosage: 10 MG Q DAY PO. During the same period patient was treated with ENALAPRIL MALEATE, TENEX, PROTONIX, CLARITIN, VITAMIN E, VITAMIN D. Patient recovered.

Health Professional from SWEDEN reported VASOTEC problem on Mar 27, 2007. Female patient, 72 years of age, was treated with VASOTEC. After drug was administered, patient experienced the following problems/side effects: haemodialysis, lactic acidosis. VASOTEC dosage: unknown. During the same period patient was treated with ZOCOR, METFORMIN, FOLIC ACID, BENDROFLUMETHIAZIDE, FUROSEMIDE, GLYBURIDE. Patient was hospitalized. Patient recovered.

VASOTEC problem was reported by a Physician from GERMANY on June 19, 2006. Female patient, 40 years of age, weighting 154.3 lb, was diagnosed with hypertension and was treated with VASOTEC. After drug was administered, patient experienced the following problems/side effects: angioedema. VASOTEC dosage: unknown. During the same period patient was treated with BISOPROLOL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from DENMARK reported VASOTEC problem on Mar 23, 2007. Female patient, 71 years of age, was diagnosed with acute coronary syndrome and was treated with VASOTEC. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, blood sodium decreased, platelet count increased, speech disorder, white blood cell count increased. VASOTEC dosage: 2.5 MG/DAILY PO. During the same period patient was treated with TAB, DIURAL, ASPIRIN, CLOPIDOGREL BISULPHATE, DIGOXIN, POTASSIUM ACETATE. Patient was hospitalized. Patient recovered.

VASOTEC problem was reported by a Consumer or non-health professional from DENMARK on Mar 23, 2007. Female patient, 71 years of age, was diagnosed with acute coronary syndrome and was treated with VASOTEC. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, blood sodium decreased, platelet count increased, speech disorder, swollen tongue, white blood cell count increased. VASOTEC dosage: 2.5 MG/DAILY PO. During the same period patient was treated with TAB, DIURAL, ASPIRIN, CLOPIDOGREL BISULPHATE, DIGOXIN, POTASSIUM ACETATE. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported VASOTEC problem on Apr 05, 2007. Male patient was diagnosed with hypertension, prostate cancer, diabetes mellitus and was treated with VASOTEC. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, cardiac enzymes increased, diabetic complication, dizziness, escherichia urinary tract infection, hypoglycaemia, skin ulcer, vascular calcification, venous stasis. VASOTEC dosage: 10 MG BID ORAL. During the same period patient was treated with COREG, LASIX, INSULIN, PLAVIX, ASPIRIN, POTASSIUM CHLORIDE, VYTORIN. Patient was hospitalized. Patient recovered.

VASOTEC problem was reported by a Consumer or non-health professional from UNITED STATES on May 03, 2006. Female patient, 76 years of age, weighting 260.0 lb, was diagnosed with nutritional support and was treated with VASOTEC. After drug was administered, patient experienced the following problems/side effects: disease recurrence, hypersensitivity, tongue oedema. VASOTEC dosage: unknown. During the same period patient was treated with BENEFIBER FIBER SUPPLEMENT. Patient recovered.

Physician from UNITED STATES reported VASOTEC problem on Jan 20, 2006. Female patient, 59 years of age, weighting 160.0 lb, was treated with VASOTEC. After drug was administered, patient experienced the following problems/side effects: angioedema. VASOTEC dosage: unknown. During the same period patient was treated with MAXZIDE, NORVASC, PEPCID, PREMARIN, TICLID, ZOCOR, HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient recovered.

VASOTEC problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 18, 2007. Female patient, weighting 178.0 lb, was diagnosed with hypertension and was treated with VASOTEC. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, dizziness, headache, insomnia, palpitations. VASOTEC dosage: 5 MG TID, ORAL; (18 YEARS UNTIL 12/??/2006). Patient recovered.

Consumer or non-health professional from UNITED STATES reported VASOTEC problem on Apr 16, 2007. Female patient, weighting 220.0 lb, was diagnosed with osteoarthritis and was treated with VASOTEC. After drug was administered, patient experienced the following problems/side effects: anaemia, anxiety, carotid artery occlusion, cerebral infarction, cerebrovascular accident, depression, diabetes mellitus, diverticulitis. VASOTEC dosage: unknown. During the same period patient was treated with VIOXX, PROCARDIA, PARACETAMOL, VALIUM, CALCIUM CHLORIDE. Patient was hospitalized. Patient recovered.

VASOTEC problem was reported by a Consumer or non-health professional from UNITED STATES on May 15, 2007. Female patient, weighting 204.0 lb, was diagnosed with hypertension and was treated with VASOTEC. After drug was administered, patient experienced the following problems/side effects: nausea, vomiting. VASOTEC dosage: unknown. During the same period patient was treated with HYDRALAZINE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported VASOTEC problem on Apr 30, 2007. Female patient was diagnosed with hypertension and was treated with VASOTEC. After drug was administered, patient experienced the following problems/side effects: feeling abnormal, palpitations, tachycardia. VASOTEC dosage: (7.5 MG TID ORAL). During the same period patient was treated with HYDROCHLOROTHIAZIDE. Patient recovered.

VASOTEC problem was reported by a Consumer or non-health professional from UNITED STATES on May 21, 2007. Male patient, weighting 195.0 lb, was diagnosed with transient ischaemic attack and was treated with VASOTEC. After drug was administered, patient experienced the following problems/side effects: renal failure. VASOTEC dosage: unknown. During the same period patient was treated with HYDROCHLOROTHIAZIDE, PLAVIX. Patient recovered.

Physician from JAPAN reported VASOTEC problem on May 18, 2007. Male patient, 61 years of age, was diagnosed with hypertension, arrhythmia, angina pectoris and was treated with VASOTEC. After drug was administered, patient experienced the following problems/side effects: adverse event, hepatic function abnormal. VASOTEC dosage: unknown. During the same period patient was treated with ASPIRIN, METOPROLOL TARTRATE, SIGMART, FRANDOL, NITRENDIPINE. Patient was hospitalized. Patient recovered.

VASOTEC problem was reported by a Consumer or non-health professional from UNITED STATES on May 09, 2007. Female patient, 66 years of age, was diagnosed with hypertension and was treated with VASOTEC. After drug was administered, patient experienced the following problems/side effects: abdominal discomfort, blood glucose increased, feeling abnormal, malaise. VASOTEC dosage: (2.5 MG QD ORAL). During the same period patient was treated with INSULIN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported VASOTEC problem on May 11, 2007. Female patient, 59 years of age, was diagnosed with arthritis and was treated with VASOTEC. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, bundle branch block left, constipation, decreased appetite, dilatation ventricular, ejection fraction decreased, myocardial ischaemia, tremor, weight increased. VASOTEC dosage: unknown. During the same period patient was treated with VIOXX, ELAVIL, HYDROXYZINE HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, ACETAMINOPHEN W, CALCIUM CHLORIDE, POTASSIUM ACETATE. Patient recovered.

VASOTEC problem was reported by a Physician from JAPAN on May 18, 2007. Male patient, 61 years of age, was diagnosed with hypertension, arrhythmia, angina pectoris and was treated with VASOTEC. After drug was administered, patient experienced the following problems/side effects: adverse event, hepatic function abnormal. VASOTEC dosage: unknown. During the same period patient was treated with ASPIRIN, METOPROLOL TARTRATE, SIGMART, FRANDOL, NITRENDIPINE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported VASOTEC problem on May 11, 2007. Female patient, weighting 178.0 lb, was diagnosed with hypertension and was treated with VASOTEC. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, colitis ulcerative, dizziness, headache, insomnia, palpitations. VASOTEC dosage: (5 MG TID ORAL). Patient recovered.

VASOTEC problem was reported by a Consumer or non-health professional from UNITED STATES on May 18, 2007. Male patient was diagnosed with hypertension and was treated with VASOTEC. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, palpitations. VASOTEC dosage: (20 MG QD ORAL). During the same period patient was treated with HYDROCHLOROTHIAZIDE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported VASOTEC problem on June 08, 2007. Female patient, 86 years of age, was diagnosed with anaemia, blood glucose abnormal, oedema and was treated with VASOTEC. After drug was administered, patient experienced the following problems/side effects: dyspnoea, eructation, retching, swelling face, vomiting. VASOTEC dosage: unknown. During the same period patient was treated with PRINIVIL, PROCRIT, CYANOCOBALAMIN, GLUCOPHAGE, LASIX. Patient recovered.

VASOTEC problem was reported by a Physician from UNITED STATES on Oct 04, 1995. Male patient, 55 years of age, was diagnosed with hypercholesterolaemia and was treated with VASOTEC. After drug was administered, patient experienced the following problems/side effects: amyotrophic lateral sclerosis, asthenia, blood creatine phosphokinase increased, dyspnoea exertional, muscular weakness. VASOTEC dosage: unknown. During the same period patient was treated with MEVACOR, LOPRESSOR, ASPIRIN. Patient died on 09/01/1995.

Consumer or non-health professional from UNITED STATES reported VASOTEC problem on June 05, 2007. Female patient, 68 years of age, weighting 185.0 lb, was diagnosed with blood pressure management and was treated with VASOTEC. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, diarrhoea, dyspnoea, flushing, immobile, nausea, rash, sensation of heaviness, tremor. VASOTEC dosage: (20 MG BID ORAL). During the same period patient was treated with NORVASC, TOPROL, PREMARIN, PROVERA, LASIX, VYTORIN, PREDNISONE. Patient recovered.

VASOTEC problem was reported by a Consumer or non-health professional from UNITED STATES on June 08, 2007. Female patient was diagnosed with anaemia, oedema and was treated with VASOTEC. After drug was administered, patient experienced the following problems/side effects: dyspnoea, eructation, haemoglobin decreased, retching, swelling face, vomiting. VASOTEC dosage: unknown. During the same period patient was treated with PROCRIT, LASIX, LISINOPRIL, VITAMIN B12 NOS, GLUCOPHAGE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported VASOTEC problem on July 12, 2006. Female patient, 58 years of age, was diagnosed with hypertension, hypothyroidism, thyroidectomy and was treated with VASOTEC. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, blood thyroid stimulating hormone increased, erythema, heart rate increased, hypertension, hypoaesthesia, mental impairment, rash. VASOTEC dosage: 5 MG TID. During the same period patient was treated with THYROID, ROCALTROL, ASPIRIN, TORSEMIDE. Patient was hospitalized. Patient recovered.

VASOTEC problem was reported by a Physician from UNITED STATES on Oct 18, 2006. Male patient, weighting 256.0 lb, was diagnosed with hypertension and was treated with VASOTEC. After drug was administered, patient experienced the following problems/side effects: cough, diarrhoea, dyspnoea, eye irritation, lacrimation increased, nausea. VASOTEC dosage: unknown. Patient recovered.

Physician from UNITED STATES reported VASOTEC problem on Sept 29, 2006. Female patient, 75 years of age, weighting 131.0 lb, was diagnosed with hypertension and was treated with VASOTEC. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, blood pressure increased, dizziness, dyspnoea, feeling abnormal, headache. VASOTEC dosage: 20 MG BID PO. During the same period patient was treated with NORVASC, COMBIVENT. Patient recovered.

VASOTEC problem was reported by a Physician from UNITED STATES on Sept 29, 2006. Female patient, 43 years of age, was treated with VASOTEC. After drug was administered, patient experienced the following problems/side effects: hepatic enzyme increased, hepatic necrosis. VASOTEC dosage: 5 MG QD PO. Patient recovered.

Consumer or non-health professional from UNITED STATES reported VASOTEC problem on Oct 30, 2006. Female patient, 57 years of age, was diagnosed with hypertension and was treated with VASOTEC. After drug was administered, patient experienced the following problems/side effects: dizziness, feeling abnormal, nausea, palpitations. VASOTEC dosage: 10 MG PO. Patient recovered.

VASOTEC problem was reported by a Physician from UNITED STATES on Nov 13, 2006. Female patient, 43 years of age, was treated with VASOTEC. After drug was administered, patient experienced the following problems/side effects: hepatic necrosis. VASOTEC dosage: 5 MG QD PO. Patient recovered.

Consumer or non-health professional from UNITED STATES reported VASOTEC problem on Nov 14, 2006. Male patient, 81 years of age, weighting 165.0 lb, was diagnosed with hypertension and was treated with VASOTEC. After drug was administered, patient experienced the following problems/side effects: blood pressure increased. VASOTEC dosage: 10 MG BID PO. During the same period patient was treated with ENALAPRIL MALEATE. Patient recovered.

VASOTEC problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 15, 2006. Female patient, 88 years of age, weighting 142.0 lb, was treated with VASOTEC. After drug was administered, patient experienced the following problems/side effects: cardiomegaly, computerised tomogram abnormal, cough, dysphagia, gastrooesophageal reflux disease, hypertension, insomnia, meniere's disease. VASOTEC dosage: unknown. During the same period patient was treated with MAXZIDE, REGLAN, ATENOLOL, MECLIZINE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported VASOTEC problem on June 20, 2007. Male patient, weighting 230.0 lb, was diagnosed with blood pressure increased and was treated with VASOTEC. After drug was administered, patient experienced the following problems/side effects: asthenia, disease recurrence, dyspnoea, heart rate increased, hypoglycaemia, irritability, malaise, sinus headache. VASOTEC dosage: (20 MG BID ORAL). Patient recovered.

VASOTEC problem was reported by a Consumer or non-health professional from UNITED STATES on June 26, 2007. Female patient, weighting 180.0 lb, was treated with VASOTEC. After drug was administered, patient experienced the following problems/side effects: colon cancer, neck pain, rash. VASOTEC dosage: (5 MG QD ORAL). Patient recovered.

Consumer or non-health professional from UNITED STATES reported VASOTEC problem on June 26, 2007. Female patient, 69 years of age, was treated with VASOTEC. After drug was administered, patient experienced the following problems/side effects: angioedema, electrocardiogram t wave inversion, hypersensitivity, hypertension, speech disorder, upper respiratory tract infection. VASOTEC dosage: unknown. During the same period patient was treated with VICKS DAYQUIL, VICKS NYQUIL, PLAVIX, PRAVACHOL, AMILORIDE HYDROCHLORIDE, ASPIRIN. Patient recovered.

VASOTEC problem was reported by a Physician from UNITED STATES on June 28, 2007. Female patient was treated with VASOTEC. After drug was administered, patient experienced the following problems/side effects: acute myocardial infarction, cardiac murmur, carotid bruit, coronary artery stenosis, cough, diastolic dysfunction, electrocardiogram st-t change, gallop rhythm present, heart rate decreased. VASOTEC dosage: unknown. During the same period patient was treated with INTEGRILIN. Patient was hospitalized. Patient recovered.

Health Professional from SPAIN reported VASOTEC problem on July 11, 2007. Male patient, 78 years of age, was treated with VASOTEC. After drug was administered, patient experienced the following problems/side effects: hyperkalaemia, hypotension, renal failure acute, syncope. VASOTEC dosage: 20 MG QD ORAL. During the same period patient was treated with VERAPAMIL, ZOCOR, ISCOVER, OMEPRAZOLE. Patient was hospitalized. Patient recovered.

VASOTEC problem was reported by a Consumer or non-health professional from UNITED STATES on July 12, 2007. Female patient, 68 years of age, weighting 185.0 lb, was diagnosed with blood pressure management and was treated with VASOTEC. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, diarrhoea, dyspnoea, flushing, immobile, nausea, palpitations, rash, sensation of heaviness. VASOTEC dosage: 20 MG BID ORAL. During the same period patient was treated with PREDNISONE, NORVASC, TOPROL, PREMARIN, PROVERA, LASIX. Patient recovered.

Physician from UNITED STATES reported VASOTEC problem on Aug 06, 2007. Male patient, 70 years of age, weighting 137.0 lb, was treated with VASOTEC. After drug was administered, patient experienced the following problems/side effects: atrioventricular block, blood creatinine increased, blood potassium increased. VASOTEC dosage: unknown. During the same period patient was treated with TEKTURNA. Patient recovered.

VASOTEC problem was reported by a Consumer or non-health professional from UNITED STATES on July 25, 2007. Male patient, 50 years of age, was treated with VASOTEC. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, dizziness, headache, hypoaesthesia, vision blurred. VASOTEC dosage: 10 MG QD ORAL. Patient recovered.

Physician from UNITED STATES reported VASOTEC problem on July 25, 2007. Female patient, 73 years of age, weighting 205.0 lb, was treated with VASOTEC. After drug was administered, patient experienced the following problems/side effects: aphasia, blood glucose increased, blood pressure systolic increased, cerebrovascular accident, dyspepsia, lung infection, musculoskeletal pain, nausea, osteoarthritis. VASOTEC dosage: (10 MG BID ORAL). During the same period patient was treated with HUMULIN, NIFEDIPINE, REGLAN, ASPIRIN, GLYBURIDE, METFORMIN. Patient was hospitalized. Patient recovered.

VASOTEC problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 09, 2007. Male patient, weighting 230.0 lb, was diagnosed with blood pressure increased and was treated with VASOTEC. After drug was administered, patient experienced the following problems/side effects: asthenia, dyspnoea, feeling abnormal, heart rate increased, hypoglycaemia, irritability, malaise, sinus headache. VASOTEC dosage: (20 MG BID ORAL). Patient recovered.

Consumer or non-health professional from UNITED STATES reported VASOTEC problem on Aug 24, 2007. Male patient, 72 years of age, was diagnosed with blood pressure, cardiac disorder and was treated with VASOTEC. After drug was administered, patient experienced the following problems/side effects: dysphagia, dysuria, haemorrhage urinary tract, laryngitis, local swelling, oral intake reduced, pharyngolaryngeal pain, prostatic specific antigen increased. VASOTEC dosage: (2.5 MG BID ORAL). During the same period patient was treated with LISINOPRIL, BISOPROLOL, ALBUTEROL, SPIRIVA. Patient was hospitalized. Patient recovered.

VASOTEC problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 24, 2007. Male patient was diagnosed with hypertension and was treated with VASOTEC. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, dizziness, electrocardiogram st-t change, haematocrit decreased, haemoglobin decreased, hypotension, renal failure. VASOTEC dosage: unknown. During the same period patient was treated with HYDRODIURIL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported VASOTEC problem on Aug 28, 2007. Female patient was diagnosed with hypertension and was treated with VASOTEC. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, nervousness, palpitations. VASOTEC dosage: (5 MG QID ORAL). During the same period patient was treated with DYAZIDE, CATAPRES, NORVASC. Patient recovered.

VASOTEC problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 13, 2007. Female patient was diagnosed with hypertension and was treated with VASOTEC. After drug was administered, patient experienced the following problems/side effects: blood pressure increased. VASOTEC dosage: 5 MG QD ORAL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported VASOTEC problem on Sept 14, 2007. Male patient, 72 years of age, was diagnosed with blood pressure, cardiac disorder and was treated with VASOTEC. After drug was administered, patient experienced the following problems/side effects: coagulopathy, dysuria, haemorrhage urinary tract, laryngitis, local swelling, pharyngolaryngeal pain, prostatic specific antigen increased. VASOTEC dosage: 2.5 MG, BID; ORAL =, (2;5 MG QD, ORAL). During the same period patient was treated with LISINOPRIL, BISOPROLOL FUMARATE, ALBUTEROL, SPIRIVA. Patient was hospitalized. Patient recovered.

Ask Our Patient Community about VASOTEC

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert
(aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol

Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol

Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
Haloperidol
This drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant

Insulin Glulisine recombinant

Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
Linezolid
This drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)
MirtazapineThis drug has as active FDA Safety Alert
MisoprostolThis drug has as active FDA Safety Alert
Mobic (meloxicam)
Modafinil
MoexiprilThis drug has as active FDA Safety Alert
MonoprilThis drug has as active FDA Safety Alert (fosinopril)
Moxifloxacin
MultiHanceThis drug has as active FDA Safety Alert (gadobenate dimeglumine)
Mycamine (micafungin)
Mylotarg (gemtuzumab ozogamicin)

back to top

N
Namenda (memantine)
NaprosynThis drug has as active FDA Safety Alert (naproxen)
NaproxenThis drug has as active FDA Safety Alert
Naratriptan
Nesiritide recombinant
Nateglinide
Natrecor (nesiritide recombinant)
NefazodoneThis drug has as active FDA Safety Alert
Nelarabine
NeoTect Kit (technetium Tc 99m depreotide)
Nesiritide recombinant
NeurontinThis drug has as active FDA Safety Alert (gabapentin)
Nexavar (sorafenib)
Nitazoxanide
Nitisinone
Norelgestromin
NovoLog (insulin aspart recombinant)
Noxafil (posaconazole)

back to top

O
Olanzapine
Olanzapine/fluoxetineThis drug has as active FDA Safety Alert
Olmesartan medoxomil
Omacor (omega-3-acid ethyl esters)
OmalizumabThis drug has as active FDA Safety Alert
Omega-3-acid ethyl esters
Omnaris (cirlesonide)
OmniscanThis drug has as active FDA Safety Alert (gadodiamide)
OptiMARK (gadoversetamide)
Optison (perflutren protein-type A microspheres)
Orencia (abatacept)
Orfadin (nitisinone)
Orlistat
Ortho Evra (norelgestromin; ethinyl estradiol)
Oseltamivir phosphate
OsmoprepThis drug has as active FDA Safety Alert (sodium phosphate)
Oxaliplatin
OxcarbazepineThis drug has as active FDA Safety Alert


back to top

P
PaceroneThis drug has as active FDA Safety Alert (amiodarone)
Palifermin
Paliperidone
PamidronateThis drug has as active FDA Safety Alert
Panitumumab
Panretin Gel (alitretinoin)
Pantoprazole
Paricalcitol
ParoxetineThis drug has as active FDA Safety Alert
PaxilThis drug has as active FDA Safety Alert (paroxetine)
Pegaptanib
Pegvisomant

Pemetrexed
PemolineThis drug has as active FDA Safety Alert
Pentobarbital and carbromal
Perflutren lipid microspheres
PerindoprilThis drug has as active FDA Safety Alert
PhenerganThis drug has as active FDA Safety Alert (promethazine)
Pimecrolimus

PioglitazoneThis drug has as active FDA Safety Alert
Placidyl (ethchlorvynol)
Plan B (levonorgestrel)
Pletal (cilostazol)
Poractant alfa
Posaconazole
Pramlintide Acetate
Precedex (dexmedetomidine)
PregabalinThis drug has as active FDA Safety Alert
Prezista (darunavir)
Prialt (ziconotide)
Priftin (rifapentine)
PrinivilThis drug has as active FDA Safety Alert (lisinopril)
ProcritThis drug has as active FDA Safety Alert (epoetin alfa)
ProHanceThis drug has as active FDA Safety Alert (gadoteridol)
PromethazineThis drug has as active FDA Safety Alert
PropofolThis drug has as active FDA Safety Alert
Prosom (estazolam)
Protonix (pantoprazole)
Protopic (tacrolimus)
Provigil (modafinil)
ProzacThis drug has as active FDA Safety Alert (fluoxetine)
Prussian blue


back to top

Q
Quazepam
Quetiapine

QuinaprilThis drug has as active FDA Safety Alert
Quinupristin

R
Rabeprazole
Radiogardase
(prussian blue)
Ramelteon
RamiprilThis drug has as active FDA Safety Alert
Ranexa (ranolazine)
Ranibizumab
Ranolazine
Rapamune (sirolimus)
Raptiva (efalizumab)
Rasagiline